We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Microorganisms Identified by Microbial Detection Array in 24 Hours

By LabMedica International staff writers
Posted on 12 May 2010
A microbial detection array provides scientists with the capability of identifying pathogens over the entire range of known viruses and bacteria.

The array detects microorganisms with the use of 388,000 probes that fit in a checkerboard pattern in the middle of a 2.54-cm wide, 7.62-cm long glass slide. It will be useful for medical professionals diagnosing diseases, regulatory agencies checking product safety, and law enforcement authorities seeking to detect bioterrorism attacks.

The current operational version of the Lawrence Livermore National Laboratory (LLMD; Livermore, CA, USA) detection array (LLMDA) contains probes that can detect more than 2,000 viruses and about 900 bacteria. Scientists will be able to detect all known bacterial and viral pathogens in comparison to current multiplex polymerase chain reaction (PCR) techniques that can at best offer detection from among 50 organisms in one test.

In an online article on April 7, 2010, in the Journal of Virology, Livermore investigators working with a scientist from the Blood Systems Research Institute (San Francisco, CA, USA) said that they used the LLMDA technology to confirm the presence of an apparently benign pig virus in a vaccine. The pig virus, porcine circovirus-1 (PCV-1), was unexpectedly found in GlaxoSmithKline's (Brentford, UK) Rotarix vaccine, which is used to prevent diarrhea in babies.

"The ability to detect the major bacterial and viral components of any sample can be used in countless different ways," said Tom Slezak, LLNL's associate program leader for Informatics. "This is important because it fills a cost-performance gap that is relevant to many missions: biodefense, public health, and product safety."

Related Links:

Lawrence Livermore National Laboratory
Blood Systems Research Institute
GlaxoSmithKline




New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Automated Nucleic Acid Extraction Instrument
EX9600
New
Bordetella Pertussis ELISA
NovaLisa Bordetella Pertussis IgA

Latest Molecular Diagnostics News

POC Sepsis Test Delivers Fast, Accurate and User-Friendly Results in Critical Care Settings

Experimental Blood Test Improves Detection of Early-Stage Pancreatic Cancer

Simple Blood Draw Helps Diagnose Lung Cancer 10 Times Faster